Induction phase | Maintenance phase | Re-warming phase | ||||
---|---|---|---|---|---|---|
Control group | PL group | Control group | PL group | Control group | PL group | |
Hematology | ||||||
Leucocytes (109/l) | 15 (12 to 19) | 14 (11 to 16) | 12 (9 to 15)† | 10 (9 to 13)† | 10 (8 to 13)† | 9 (8 to 11)† |
Thrombocytes (109/l) | 207 (168 to 249) | 259 (217 to 288) | 192 (155 to 227) | 197 (183 to 248) | 149 (116 to 205)† | 167 (152 to 196)† |
Hemoglobin (mmol/l) | 7.5 (6.5 to 8.6) | 8.7 (8.3 to 9.2)* | 7.4 (6.5 to 8.5) | 8.2 (7.5 to 8.8) | 7.1 (6.3 to 7.8) | 7.7 (6.8 to 8.3)† |
Hematocrit | 0.35 (0.31 to 0.42) | 0.40 (0.39 to 0.44)* | 0.36 (0.31 to 0.41) | 0.37 (0.35 to 0.40) | 0.35 (0.31 to 0.38) | 0.34 (0.33 to 0.38)† |
PT (sec) | 1.32 (1.19 to 1.57) | 1.23 (1.20 to 1.51) | 1.30 (1.20 to 1.52) | 1.16 (1.15 to 1.28) | 1.34 (1.22 to 1.54) | 1.25 (1.21 to 1.60) |
aPTT (sec) | 74 (43 to 164) | 107 (79 to 240) | 83 (50 to 111) | 87 (50 to 109) | 68 (55 to 86) | 76 (69 to 89)† |
Renal function | ||||||
Serum creatinine (μmol/l) | 96 (78 to 125) | 96 (89 to 99) | 89 (62 to 134) | 92 (79 to 105) | 100 (65 to 155) | 113 (78 to 151) |